Breaks Categories: News

TuesdayOct 10, 2017 2:46 pm

CannabisNewsBreaks – Global Payout, Inc. (GOHE) Subsidiary Finalizing JV Partnership Aimed at Bringing Banking Solutions to the Cannabis Industry

Payment solutions company Global Payout, Inc. (OTC: GOHE) today announced that MoneyTrac Technology, Inc., its majority-owned subsidiary, is currently in the final stages of facilitating an exclusive joint venture partnership agreement aimed at bringing effective banking solutions to businesses operating in the rapidly expanding cannabis industry. The company anticipates significant revenue earning opportunities to stem from this agreement upon its final execution. “The potential surrounding the anticipated completion of this Joint Venture is absolutely huge for our MoneyTrac Technology brand,” MoneyTrac CEO James Hancock stated in the news release. “MoneyTrac was launched almost exclusively to address the many different challenges…

Continue Reading

TuesdayOct 10, 2017 1:14 pm

CannabisNewsBreaks – Grey Cloak Tech, Inc.’s (GRCK) Acquisition Target Eqova Debuts New CannaBio Salve at Denver’s Integrative Medicine Summit

Grey Cloak Tech (OTC: GRCK) this morning said that Eqova Live Sciences, the company’s acquisition target, exhibited at Denver's Integrative Medicine Summit in Denver, Colorado, on October 7, 2017. Grey Cloak signed a Letter of Intent to acquire Eqova Life Sciences on September 19, 2017. Eqova Life Sciences develops clinical grade Full Spectrum Hemp Oil products that are sold exclusively through partnerships with licensed medical practitioners to use with their patients. Eqova debuted its new CannaBio Salve, an innovative topical salve with several aromatic natural oils, at the summit, which was attended by over 200 medical professionals. Eqova was the…

Continue Reading

TuesdayOct 10, 2017 10:40 am

CannabisNewsBreaks – Marijuana Company of America (MCOA) and Global Hemp Group Enter Letter of Intent to Form Joint Venture with Space Cowboys, Inc.

Marijuana Company of America (OTC: MCOA) and Global Hemp Group (OTC: GBHPF) (CSE: GHG) this morning announced their entry into a letter of intent with licensed cannabinoid producer Space Cowboys, Inc. for the purposes of forming a joint venture. Per the terms of the agreement, the two companies will invest $2.5 million in exchange for a 25 percent equity interest in Space Cowboys, subject to their ability to obtain sufficient funding. These funds will be used to expand Space Cowboys’ cultivation operations in an effort to better capitalize on the strong demand for cannabinoid-based products within Colorado’s established legal cannabis…

Continue Reading

TuesdayOct 10, 2017 10:15 am

CannabisNewsBreaks – PotNetwork Holding, Inc. (POTN) Announces Appointment of Dr. Michael McKenzie to Advisory Board

PotNetwork Holding, Inc. (OTC: POTN) this morning announced its appointment of Dr. Michael McKenzie, an industry-leading physician, to its advisory board, effectively furthering its strategy centered on formulating, producing and marketing a spectrum of exclusive and diversely targeted cannabidiol blends. As noted in this morning’s update, Dr. McKenzie has positioned himself at the forefront of the medical marijuana industry by gaining a keen understanding of cannabis and its specific impact on a number of unique illnesses. “Dr. McKenzie is going to be an invaluable addition to our team. He has already been very instrumental in providing valuable guidance, and has…

Continue Reading

TuesdayOct 10, 2017 9:51 am

CannabisNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Announces Addition of Dr. Mauro Maccarrone to Scientific Advisory Board

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced the addition of Dr. Mauro Maccarrone to its scientific advisory board. Maccarrone is professor and chair of biochemistry and molecular biology at Campus Bio-Medico, University of Rome. He also serves as director of the Laboratory of Lipid Neurochemistry of the European Center for Brain Research-IRCCS Santa Lucia Foundation in Rome. “InMed is dedicated to developing industry-leading products in diseases with high unmet medical needs. One key element in drug development is to ensure that we are working with leading scientists in the field who can contribute their…

Continue Reading

MondayOct 09, 2017 12:16 pm

CannabisNewsBreaks – 22nd Century Group, Inc. (NYSE: XXII) Announces $54M Common Stock Only Registered Direct Offering

22nd Century Group (NYSE MKT: XXII) this morning said that it has entered into an agreement with institutional investors to collect approximately $54 million in gross proceeds in a registered direct offering from the sale of 20.57 million shares of common stock at a price of $2.625 per share. Total proceeds will raise the company’s cash balance to over $60 million, which covers all regular operating expenses for more than five years. Subject to customary closing conditions, the offering is anticipated to close on or about October 10, 2017. “More than $50 million in net proceeds will significantly improve our…

Continue Reading

ThursdayOct 05, 2017 9:25 am

CannabisNewsBreaks – EVIO, Inc. (EVIO) Providing Accredited Testing Services to Oregon’s Industrial Hemp Sector

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis analytical testing services, this morning announced that it is now prepared to offer accredited testing services to Oregon’s industrial hemp sector. “Industrial hemp is a rapidly growing industry with product applications ranging from foods like hemp seed, personal care products, textiles, and other industrial and consumer goods such as building materials,” Lori Glauser, COO of EVIO, stated in the news release. “In fact, hemp-based CBD oil alone is projected to reach $1 billion in sales by 2020, and, notably, big box stores like Target and Wal Mart are already offering the…

Continue Reading

WednesdayOct 04, 2017 10:32 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Provides Update on In Vitro Data Related to IGC-AD1

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning provided an update on compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model showing that, at varying concentrations of IGC-AD1, mitochondrial function is enhanced by 30-60 percent. “Based on our analysis of this and other previously announced compelling data, we are readying IGC-AD1 in a liquid formulation that will not cause inebriation,” Ram Mukunda, CEO of IGC, stated in the news release. “The initial commercialization will be through licensed medical cannabis dispensaries.” As…

Continue Reading

WednesdayOct 04, 2017 10:05 am

CannabisNewsBreaks – PotNetwork Holding, Inc. (POTN) Names Dr. Richard Goulding as New Chief Executive Officer

PotNetwork Holding, Inc. (OTC: POTN) this morning announced, as part of its strategy to formulate, produce and market a spectrum of exclusive and diversely targeted cannabidiol blends, its appointment of Richard Goulding, MD as its new chief executive officer. Per the news release, Goulding is expected to play a key role in directing PotNetwork’s endeavors to develop targeted formulas designed to deliver results for a diverse spectrum of challenges that can be aided by cannabidiol. “We believe, based on studies and reports, that CBD can contribute impressively to quality of life in those that are able to benefit from its…

Continue Reading

WednesdayOct 04, 2017 9:36 am

CannabisNewsBreaks – Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) Enters Collaboration and Licensing Agreement with Canntab Therapeutics

Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) yesterday announced its entry into a collaboration and licensing agreement with Canntab Therapeutics Limited, developer of a patent-pending oral sustained release formulation for cannabinoids. Per the terms of the agreement, Emblem and Canntab will collaborate on the preclinical formulation, clinical development, regulatory approval, manufacturing and commercialization of this sustained release product, with Emblem receiving the exclusive right in Canada to Canntab’s patents and know-how for the purpose of developing and commercializing the innovative product under the Emblem brand. Manufacture of the sustained release product is expected to be completed by Emblem or Canntab following…

Continue Reading